April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Hypoxia-stimulated STAT3-dependent VEGF Expression in Retinal Endothelial Cells Involves Activation of Histone Deacetylase 6 (HDAC6)
Author Affiliations & Notes
  • Chaunte Stampley
    Ophthalmology,
    Medical College of Georgia, Augusta, Georgia
  • Anna Lisa Montemari
    Fondazione GB Bietti IRCCS, Rome, Italy
  • Folami Lamoke
    Ophthalmology, Pharmacology and Toxicology,
    Medical College of Georgia, Augusta, Georgia
  • Curran Dalal
    Ophthalmology,
    Medical College of Georgia, Augusta, Georgia
  • Dennis Marcus
    Ophthalmology, Southeast Retina Center, Augusta, Georgia
  • Manuela Bartoli
    Ophthalmology, Pharmacology and Toxicology,
    Medical College of Georgia, Augusta, Georgia
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 4359. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Chaunte Stampley, Anna Lisa Montemari, Folami Lamoke, Curran Dalal, Dennis Marcus, Manuela Bartoli; Hypoxia-stimulated STAT3-dependent VEGF Expression in Retinal Endothelial Cells Involves Activation of Histone Deacetylase 6 (HDAC6). Invest. Ophthalmol. Vis. Sci. 2011;52(14):4359.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : We have previously shown that persistent activation of the transcription factor (TF) signal transducer and activator of transcription 3 (STAT3) leads to hypoxia-induced VEGF expression in the ischemic retina and in retinal cells exposed to hypoxia. Recent studies have also shown that cytosolic histone deacetylases (HDACs) may control the activity of TFs including STAT3. Here we wanted to investigate the specific role of HDAC6, a cytosolic HDAC, on hypoxia-induced STAT3 activation and STAT3-dependent VEGF expression

Methods: : Retinal microvascular endothelial cells (REC) were exposed to hypoxic condition (pO2=2%) for different times (10, 30 and 60 minutes and for 6,12 and 24 hours). Western blotting analysis was conducted to determine phosphorylation/activation of STAT3 and VEGF protein levels. Immunoprecipitation was performed to determine HDAC6 and STAT3 interaction. Chromatin immunoprecipitation (ChIP) was conducted to assess STAT3 binding to VEGF promoter. HDAC6 activity was measured by determining deacetylation of alpha tubulin. Selective blockade of HDAC6 was achieved by transfection of RECs with specific siRNAs

Results: : Hypoxia- stimulated HDAC6 activity, as shown by decreased acetylation of apha tubulin. This effect was associated with increased STAT3 activation (10 and 30 minutes) and binding to VEGF promoter (10 minutes). Hypoxia also stimulated HDAC6 interaction with STAT3 at the same time points. Transfection of RECs with HDAC6 specific siRNAs did not affect hypoxia-induced STAT3 phosphorylation, but blunted its ability to bind VEGF promoter and stimulate VEGF expression

Conclusions: : Our data suggest that STAT3 interaction with HDAC6 is necessary to transcription factor binding to VEGF promoter and induction of gene expression. Targeting of HDAC6 may have therapeutic value for the treatment of ischemic retinopathies

Keywords: neovascularization • vascular endothelial growth factor • hypoxia 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×